In Pharmaceutical Manufacturing Construction and Technology
At procurement, qualification and validation
Last April, our team attended INTERPHEX 2026, one of the leading global pharmaceutical and biotechnology events, bringing together innovation, technology, and expert-led education across the life sciences industry.
There is a common misconception that “bio-based” means “compostable” or “weak.” In the high-stakes world of biopharmaceutical manufacturing, that couldn’t be further from the truth.
As we scale up single-use technologies (SUT) in 2026, understanding the origins and particularities of these materials is a compliance and sustainability imperative.
As we move through 2026, the biopharma industry is hitting a major sustainability milestone. For years, the move to Single-Use Technology (SUT) was criticized for its plastic waste. Today, one step towards solving that paradox that has been presented is Bio-based Polymers.
Today, we’re proud to introduce Owen McMaster, our motivated and resourceful Project Manager / Engineer-in-Training (EIT).
Copyright (c) 2025, GPharma Solutions Ltd; all rights reserved.
Template by Bootstrapious. Ported to Hugo by DevCows.
